mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.007 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.007 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.007 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.01 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
ZSTK474 |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.01 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.02 |